Newton Fund UK-China collaboration to tackle antimicrobial resistance (registration of interest deadline: 30th May; proposal submission deadline: 14th June 2018)
UK researchers can apply for a share of up to £10 million for joint projects with Chinese partners to tackle antimicrobial resistance (AMR).
Call Type: Bilateral, academia-industry consortia
The Department of Health and Social Care (DHSC) is working with Innovate UK to invest up to £10 million of Official Development Assistance (ODA) funding. This will be in bilateral research and development (R&D) projects between the UK and China. The funding will address the growing threat of antimicrobial resistance (AMR).
Objective
This competition is for innovative projects that support the development and, where appropriate, clinical evaluation of new products or services. These products or services must be of value in addressing the threat from AMR.
UK applicants must demonstrate that projects are primarily and directly relevant to the needs of people in low and middle income countries (LMICs), including China, as defined by the Organisation for Economic Co-operation and Development (OECD). There must be a clear economic and societal benefit to LMICs from their proposed project.
Eligibility
The lead applicant for a UK project must be a UK based business, and can be any size.
UK partnerships must:
- make sure that at least 20% of the overall UK project costs are incurred by one business or more
- comply with ODA guidelines
Your consortium must conduct the project in the UK and China, and contain at least:
- one UK based business
- one UK academic or research organisation
- one business based in mainland China
- one academic or research organisation based in mainland China
Funding level
Up to £10 million to fund the UK side of innovation projects, as part of the Global AMR Innovation Fund.
Up to £750,000 to be shared between the UK members of each consortium.